bioMérieux S.A. (BMXMF)

R&D Expenses

€257.01M

Quarterly · Period ending: · EUR

BMXMF logo

BMXMF R&D Expenses

Latest reported€257.01M EUR
BMXMF Quarterly R&D Expenses · EUR (€143.00M → €257.01M)
High-resolution chart · PNG

BMXMF r&d expenses history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. R&D Expenses — Quarterly (EUR)
Period endingR&D Expenses (EUR)
257,014,687
271,198,387
414,000,000
230,900,000
260,600,000
233,600,000
226,500,000
239,300,000
207,300,000
207,500,000
181,500,000
195,200,000
200,500,000
194,500,000
178,000,000
211,500,000
156,200,000
155,900,000
148,500,000
146,400,000
125,500,000
123,000,000
115,900,000
106,000,000
99,800,000
101,100,000
90,700,000
143,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.